Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma ; volume:38 ; number:12 ; day:16 ; month:9 ; year:2024 ; pages:2663-2674 ; date:12.2024
Leukemia ; 38, Heft 12 (16.9.2024), 2663-2674, 12.2024
- Creator
-
Willis, Brandon S.
Mongeon, Kevin
Dry, Hannah
Neveras, India L.
Bryan, Nadezda
Pandya, Meghana
Roderick-Richardson, Justine
Xu, Wendan
Yang, Li
Rosen, Alan
Reimer, Corinne
Tuskova, Liliana
Klener, Pavel
Mettetal, Jerome T.
Lenz, Georg
Barry, Simon T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02401-9
- URN
-
urn:nbn:de:101:1-2502102141116.476635358386
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Willis, Brandon S.
- Mongeon, Kevin
- Dry, Hannah
- Neveras, India L.
- Bryan, Nadezda
- Pandya, Meghana
- Roderick-Richardson, Justine
- Xu, Wendan
- Yang, Li
- Rosen, Alan
- Reimer, Corinne
- Tuskova, Liliana
- Klener, Pavel
- Mettetal, Jerome T.
- Lenz, Georg
- Barry, Simon T.
- SpringerLink (Online service)